TriSalus Research Development vs Net Income From Continuing Ops Analysis

TLSIW Stock

1.02 0.09 9.68%

TriSalus Life financial indicator trend analysis is much more than just breaking down TriSalus Life Sciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether TriSalus Life Sciences is a good investment. Please check the relationship between TriSalus Life Research Development and its Net Income From Continuing Ops accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TriSalus Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Research Development vs Net Income From Continuing Ops

Research Development vs Net Income From Continuing Ops Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of TriSalus Life Sciences Research Development account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have pay attention.

The correlation between TriSalus Life's Research Development and Net Income From Continuing Ops is -0.96. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of TriSalus Life Sciences, assuming nothing else is changed. The correlation between historical values of TriSalus Life's Research Development and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of TriSalus Life Sciences are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Research Development i.e., TriSalus Life's Research Development and Net Income From Continuing Ops go up and down completely randomly.

Correlation Coefficient

-0.96

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Research Development

Net Income From Continuing Ops

Most indicators from TriSalus Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into TriSalus Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TriSalus Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Tax Provision is likely to drop to 7,700 in 2024. Selling General Administrative is likely to drop to about 30.4 M in 2024

	2010	2022	2023	2024 (projected)
Gross Profit	7.2M	10.1M	15.9M	12.2M
Total Revenue	8.4M	12.4M	18.5M	14.4M

Gross Profit Total Revenue

TriSalus Life fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Capital Stock	Non Current Liabilities Other	Net Working Capital
Total Assets		-0.61	-0.93	-0.48	-0.99	0.9	-0.98	0.99	-0.98	-0.95	-0.7	-0.58	0.71	-0.74	0.59	-0.48	-0.98	1.0	0.98	-0.73	0.96
Other Current Liab	-0.61		0.86	-0.39	0.65	-0.22	0.76	-0.63	0.57	0.48	0.0	-0.06	0.12	0.05	0.27	-0.39	0.52	-0.63	-0.67	-0.09	-0.8
Total Current Liabilities	-0.93	0.86		0.12	0.93	-0.68	0.98	-0.92	0.88	0.81	0.42	0.38	-0.39	0.47	-0.24	0.12	0.86	-0.93	-0.93	0.42	-0.99
Total Stockholder Equity	-0.48	-0.39	0.12		0.45	-0.81	0.3	-0.48	0.54	0.61	0.86	0.67	-0.96	0.86	-0.99	1.0	0.58	-0.47	-0.42	0.95	-0.24
Property Plant And Equipment Net	-0.99	0.65	0.93	0.45		-0.88	0.99	-1.0	0.99	0.97	0.72	0.48	-0.68	0.76	-0.55	0.45	0.99	-1.0	-1.0	0.69	-0.97
Retained Earnings	0.9	-0.22	-0.68	-0.81	-0.88		-0.8	0.89	-0.92	-0.93	-0.89	-0.71	0.94	-0.91	0.88	-0.81	-0.94	0.9	0.86	-0.95	0.76
Accounts Payable	-0.98	0.76	0.98	0.3	0.99	-0.8		-0.98	0.96	0.91	0.59	0.42	-0.55	0.64	-0.42	0.3	0.94	-0.98	-0.99	0.57	-1.0
Cash	0.99	-0.63	-0.92	-0.48	-1.0	0.89	-0.98		-1.0	-0.98	-0.74	-0.48	0.7	-0.78	0.58	-0.48	-0.99	1.0	1.0	-0.72	0.97
Non Current Assets Total	-0.98	0.57	0.88	0.54	0.99	-0.92	0.96	-1.0		0.99	0.79	0.49	-0.75	0.83	-0.64	0.54	1.0	-0.99	-0.99	0.76	-0.94
Non Currrent Assets Other	-0.95	0.48	0.81	0.61	0.97	-0.93	0.91	-0.98	0.99		0.87	0.44	-0.8	0.9	-0.7	0.61	0.99	-0.96	-0.97	0.81	-0.89
Net Receivables	-0.7	0.0	0.42	0.86	0.72	-0.89	0.59	-0.74	0.79	0.87		0.39	-0.92	1.0	-0.89	0.86	0.82	-0.71	-0.72	0.91	-0.55
Common Stock Shares Outstanding	-0.58	-0.06	0.38	0.67	0.48	-0.71	0.42	-0.48	0.49	0.44	0.39		-0.71	0.44	-0.7	0.67	0.51	-0.54	-0.43	0.73	-0.38
Non Current Liabilities Total	0.71	0.12	-0.39	-0.96	-0.68	0.94	-0.55	0.7	-0.75	-0.8	-0.92	-0.71		-0.93	0.99	-0.96	-0.78	0.7	0.66	-1.0	0.5
Inventory	-0.74	0.05	0.47	0.86	0.76	-0.91	0.64	-0.78	0.83	0.9	1.0	0.44	-0.93		-0.89	0.86	0.85	-0.75	-0.75	0.93	-0.6
Total Liab	0.59	0.27	-0.24	-0.99	-0.55	0.88	-0.42	0.58	-0.64	-0.7	-0.89	-0.7	0.99	-0.89		-0.99	-0.68	0.58	0.53	-0.98	0.36
Net Invested Capital	-0.48	-0.39	0.12	1.0	0.45	-0.81	0.3	-0.48	0.54	0.61	0.86	0.67	-0.96	0.86	-0.99		0.58	-0.47	-0.42	0.95	-0.24
Property Plant And Equipment Gross	-0.98	0.52	0.86	0.58	0.99	-0.94	0.94	-0.99	1.0	0.99	0.82	0.51	-0.78	0.85	-0.68	0.58		-0.98	-0.98	0.8	-0.92
Total Current Assets	1.0	-0.63	-0.93	-0.47	-1.0	0.9	-0.98	1.0	-0.99	-0.96	-0.71	-0.54	0.7	-0.75	0.58	-0.47	-0.98		0.99	-0.72	0.97
Capital Stock	0.98	-0.67	-0.93	-0.42	-1.0	0.86	-0.99	1.0	-0.99	-0.97	-0.72	-0.43	0.66	-0.75	0.53	-0.42	-0.98	0.99		-0.67	0.98
Non Current Liabilities Other	-0.73	-0.09	0.42	0.95	0.69	-0.95	0.57	-0.72	0.76	0.81	0.91	0.73	-1.0	0.93	-0.98	0.95	0.8	-0.72	-0.67		-0.52
Net Working Capital	0.96	-0.8	-0.99	-0.24	-0.97	0.76	-1.0	0.97	-0.94	-0.89	-0.55	-0.38	0.5	-0.6	0.36	-0.24	-0.92	0.97	0.98	-0.52

Click cells to compare fundamentals

TriSalus Life Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for TriSalus Stock Analysis

When running TriSalus Life's price analysis, check to measure TriSalus Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TriSalus Life is operating at the current time. Most of TriSalus Life's value examination focuses on studying past and present price action to predict the probability of TriSalus Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TriSalus Life's price. Additionally, you may evaluate how the addition of TriSalus Life to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

TriSalus Research Development vs Net Income From Continuing Ops Analysis

Research Development vs Net Income From Continuing Ops

Research Development vs Net Income From Continuing Ops Correlation Analysis

Correlation Coefficient

Research Development

Net Income From Continuing Ops

TriSalus Life fundamental ratios Correlations

TriSalus Life Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for TriSalus Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash
Capital Stock	+ 1.0	Cash
Property Plant And Equipment Gross	+ 1.0	Non Current Assets Total
Inventory	+ 1.0	Net Receivables

Non Current Liabilities Other	- 1.0	Non Current Liabilities Total
Non Current Assets Total	- 1.0	Cash
Net Working Capital	- 1.0	Accounts Payable
Capital Stock	- 1.0	Property Plant And Equipment Net
Total Current Assets	- 1.0	Property Plant And Equipment Net
Cash	- 1.0	Property Plant And Equipment Net